BEEPZ Ltd 2012 © All rights reserved.   Design by Mike | Disclaimer   FAQ



Who is Botanical Extracts EPZ Limited?

BEEPZ is a private limited liability company whose primary business is the production of high-quality Artemisinin.BEEPZ is located inside the Export Processing Zone in Athi River, Kenya. BEEPZ owns three production subsidiaries operating in East Africa.

East African Botanicals Limited  in EPZ Athi River, Kenya

African Artemisia Limited in Arusha, Tanzania

What countries do you work in?

We have a network of farmers in Kenya, Uganda and Tanzania, a major extraction and purification plant in Kenya.

Where can Artemisia annua be grown?

Artemisia annua is temperate plant which is best grown at an altitude of between 1,500 meters to 2,000 meters above sea level.It requires an annual rainfall of between 700mms to 800 mms p.a. and therefore grows very well in select areas of East Africa – typically traditional coffee growing areas.

What are the ideal soil conditions for growing Artemisia annua?

Artemisia annua will grow in a wide range of soils.Ideally soils should have a PH of 5.5 to 6.5 and be deeply cultivated and well drained.

How much money am I able to make from growing Artemisia annua?

Farmers can expect to receive a payment per ton of dried and sieved leaf delivered to one of our leaf collection depots at the contracted rate.

How do I become a farmer for Botanical Extracts EPZ Limited?

Contact BEEPZ at or +254 (0)45 6622168 / 6622012 / 6622133 for more information on farming.

What is artemisinin?

Artemisinin is a plant extract from the Artemisia annua plant. It is used to treat multi-drug resistant strains of falciparum malaria.

What is malaria?

Malaria is a potentially fatal blood disease caused by a parasite that is transmitted to human and animal hosts by mosquitoes.

Where in the world has malaria been known to occur?

Malaria is endemic in nearly 100 countries worldwide. 9 out of 10 cases and 90% of the deaths caused by malaria occur in sub-Saharan Africa.

What is the impact of malaria?

300-500 million acute cases of malaria occur worldwide annually resulting in 1 million deaths.

What is the problem with treatments for malaria?

The malaria parasite is developing resistance to older, inexpensive, single drugs (mono-therapies) such as chloroquine, amodiaquine or sulfadoxine–pyrimethamine which have been effective in the past.

What can be used to treat drug resistant malaria?

The most promising and efficacious malaria treatment available to date are Artemisinin-based Combination Therapies, commonly known as ACTs

What is an ACT?

An ACT is an artemisinin-based combination therapy.ACTs have been recommended by the WHO has the first line of treatment for multi-drug resistant malaria.

Who makes ACTs?

Currently there are a few select pharmaceutical companies manufacturing high-quality ACTs. An example is Novartis, the manufacturer of Coartemtm, currently the most widely used combination therapy.

Why is artemisinin used as a combination therapy?

Combining artemisinin with another drug that has a different mode of action potentiates the action of artemisinin and delays the development of resistance to both drugs.

Is there a vaccine for malaria?

No.Experts estimate that an effective vaccine against malaria will not be available for at least another five years. Even when an effective vaccine is discovered, public health programs will inevitably face problems in deploying it. Anti-malarial drugs and preventive tools will still be necessary, as will effective policies designed to ensure they reach those at risk.

• Artemisinin and Malaria Treatments

• Impact of Malaria

BEEPZ an Overview

• Artemisia Annua Facts Sheet

• Click here to see BEEPZ Pictorial